BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1325593)

  • 1. Glycolipids of a human glioma cell line bearing receptors for platelet-derived growth factor (PDGF).
    Yates AJ; Agudelo JD; Sung CC
    Lipids; 1992 Apr; 27(4):308-10. PubMed ID: 1325593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.
    Van Brocklyn J; Bremer EG; Yates AJ
    J Neurochem; 1993 Jul; 61(1):371-4. PubMed ID: 8515285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells.
    Ariga T; Bhat S; Kanda T; Yamawaki M; Tai T; Kushi Y; Kasama T; Handa S; Yu RK
    Glycoconj J; 1996 Apr; 13(2):135-45. PubMed ID: 8737237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.
    Yates AJ; Saqr HE; Van Brocklyn J
    J Neurooncol; 1995; 24(1):65-73. PubMed ID: 8523078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells.
    Hynds DL; Summers M; Van Brocklyn J; O'Dorisio MS; Yates AJ
    J Neurochem; 1995 Nov; 65(5):2251-8. PubMed ID: 7595514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides and neutral glycolipids in guinea pig adrenal glands.
    Sekine M; Ariga T; Miyatake T; Kase R; Suzuki A; Yamakawa T
    J Biochem; 1984 Jul; 96(1):237-44. PubMed ID: 6490601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
    Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
    Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gangliosides and neutral glycolipids in ependymal, neuronal and primitive neuroectodermal tumors.
    Yates AJ; Franklin TK; McKinney P; Collins R; Comas T; Boesel CP; Pearl DK
    J Mol Neurosci; 1999 Apr; 12(2):111-21. PubMed ID: 10527455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolipid changes in murine myelogenous leukemias: neutral glycolipids as markers for specific populations of leukemias.
    Ariga T; Yoshida K; Nemoto K; Seki M; Miyatani N; Yu RK
    Biochemistry; 1991 Aug; 30(32):7953-61. PubMed ID: 1868069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma.
    Nistér M; Heldin CH; Westermark B
    Cancer Res; 1986 Jan; 46(1):332-40. PubMed ID: 2998609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides inhibit PDGF-induced signal transduction events in U-1242 MG human glioma cells.
    Saqr HE; Walters JD; Guan Z; Stokes BT; Yates AJ
    Neurochem Res; 1995 Nov; 20(11):1389-95. PubMed ID: 8786826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
    Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
    Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of complex gangliosides of human glioma cells during mitotic cell division.
    Choi BO; Yamaki T; Tatewaki K; Ibayashi Y; Hashi K
    J Neurooncol; 1997 Sep; 34(3):211-9. PubMed ID: 9258813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides and neutral glycolipids of human adrenal medulla.
    Ariga T; Ando S; Takahashi A; Miyatake T
    Biochim Biophys Acta; 1980 Jun; 618(3):480-5. PubMed ID: 7397210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity.
    Nistér M; Heldin CH; Wasteson A; Westermark B
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):926-30. PubMed ID: 6322178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
    Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
    Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The composition of glycosphingolipids and the effect of neuraminidase on cultured glioma cell lines].
    Li ZX; Iwamori M; Nagai Y; Shitara N; Takakura K
    No To Shinkei; 1989 Apr; 41(4):347-52. PubMed ID: 2765299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside expression in human pancreatic islets.
    Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
    Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipids in rat cochlea.
    Maguchi S; Gasa S; Matsushima J; Saga Y; Kawano M; Makita A
    Auris Nasus Larynx; 1991; 18(1):1-8. PubMed ID: 1892451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor in human glioma.
    Westermark B; Heldin CH; Nistér M
    Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.